4.6 Editorial Material

Inflamed fat and mitochondrial dysfunction in end-stage renal disease links to hypoxia-could curcumin be of benefit?

期刊

NEPHROLOGY DIALYSIS TRANSPLANTATION
卷 32, 期 6, 页码 909-912

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfx052

关键词

-

资金

  1. Heart and Lung Foundation
  2. Njurfonden

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Nutrition & Dietetics

Low-Plasma Insulin-Like Growth Factor-1 Associates With Increased Mortality in Chronic Kidney Disease Patients With Reduced Muscle Strength

Zhimin Chen, Erik Nilsson, Bengt Lindholm, Olof Heimburger, Peter Barany, Peter Stenvinkel, Abdul Rashid Qureshi, Jianghua Chen

Summary: Chronic kidney disease (CKD) is associated with metabolic and nutritional abnormalities, including resistance to insulin-like growth factor-1 (IGF-1) and reduced muscle mass and strength. Low levels of IGF-1 and hand-grip muscle strength (HGS) are independent predictors of increased mortality in CKD patients. The association of IGF-1 with survival in CKD patients depends on nutritional status.

JOURNAL OF RENAL NUTRITION (2023)

Review Urology & Nephrology

Updates on hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of renal anemia

Jing Li, Volker H. H. Haase, Chuan-Ming Hao

Summary: HIF-PHI is an effective class of drugs for treating renal anemia, promoting erythropoiesis and increasing hemoglobin levels. Roxadustat's erythropoiesis effect is less affected by inflammation, but thromboembolic events and tumors need to be carefully monitored during treatment.

KIDNEY DISEASES (2023)

Article Cardiac & Cardiovascular Systems

Accelerated Vascular Aging in Chronic Kidney Disease: The Potential for Novel Therapies

S. Hobson, S. Arefin, A. Witasp, L. Hernandez, K. Kublickiene, P. G. Shiels, P. Stenvinkel

Summary: The pathophysiology of vascular disease is associated with accelerated biological aging and a combination of various risk factors. Chronic kidney disease (CKD) serves as a valuable model to study the structural, functional, and molecular aspects of arterial aging. The cardiorenal syndrome results from the detrimental interaction between the kidney and the cardiovascular system. Understanding the molecular mechanisms of uremic early vascular aging provides insights into inflammatory pathways and emerging risk factors, offering new prospects for pharmacological and nutritional interventions.

CIRCULATION RESEARCH (2023)

Article Biochemistry & Molecular Biology

Indoxyl Sulphate Retention Is Associated with Microvascular Endothelial Dysfunction after Kidney Transplantation

Sam Hobson, Samsul Arefin, Awahan Rahman, Leah Hernandez, Thomas Ebert, Henriette de Loor, Pieter Evenepoel, Peter Stenvinkel, Karolina Kublickiene

Summary: Kidney transplantation is the preferred treatment for chronic kidney disease patients, offering improved quality of life and reduced mortality compared to dialysis. However, cardiovascular disease remains a leading cause of death in this population. A study investigated the functional properties of blood vessels two years after kidney transplantation and found that vessel stiffness improved while endothelial function worsened. Additionally, higher levels of a particular compound, indoxyl sulphate, were associated with decreased endothelial function and increased P-selectin levels after transplantation. Further experiments revealed that indoxyl sulphate impaired endothelium-dependent relaxation, potentially contributing to cardiovascular risk.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Blood-Brain Barrier Biomarkers before and after Kidney Transplantation

Leah Hernandez, Liam J. Ward, Samsul Arefin, Peter Barany, Lars Wennberg, Magnus Soderberg, Stefania Bruno, Vincenzo Cantaluppi, Peter Stenvinkel, Karolina Kublickiene

Summary: Kidney transplantation (KT) can improve the neurological status of chronic kidney disease (CKD) patients by affecting circulating BBB-specific biomarkers. This study compared the levels of specific biomarkers in kidney-failure patients before and after KT, showing decreased levels of NSE and increased levels of BDNF and NfL at the two-year follow-up. Male patients had higher BDNF levels compared to females. KT can improve the neurological status of CKD patients, as indicated by changes in BBB-specific biomarkers.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Associations of Biopterins and ADMA with Vascular Function in Peripheral Microcirculation from Patients with Chronic Kidney Disease

Samsul Arefin, Lars Lofgren, Peter Stenvinkel, Anna B. Granqvist, Karolina Kublickiene

Summary: We investigated the changes in plasma amino acid (AA) metabolism in patients with chronic kidney disease (CKD) and their relationship with endothelial and vascular smooth muscle function. The study found that CKD patients had altered levels of AAs and their metabolites, which were associated with abnormal vascular maintenance. These findings suggest that targeting AA metabolism could be a potential treatment option for CKD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Urology & Nephrology

Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Elaine Ku, Lucia Del Vecchio, Kai-Uwe Eckardt, Volker H. Haase, Kirsten L. Johansen, Masaomi Nangaku, Navdeep Tangri, Sushrut S. Waikar, Andrzej Wiecek, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer, David C. Wheeler

Summary: Anemia is common in chronic kidney disease patients and is associated with adverse clinical outcomes. Recent research has focused on hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) as a potential treatment for anemia in these patients.

KIDNEY INTERNATIONAL (2023)

Article Cell Biology

Implications of Senescent Cell Burden and NRF2 Pathway in Uremic Calcification: A Translational Study

Jonas Laget, Sam Hobson, Karen Muyor, Flore Duranton, Irene Cortijo, Piotr Bartochowski, Bernard Jover, Anne-Dominique Lajoix, Magnus Soderberg, Thomas Ebert, Peter Stenvinkel, Angel Argiles, Karolina Kublickiene, Nathalie Gayrard

Summary: Increased senescent cell burden and dysregulation of the NRF2 pathway play a role in vascular calcification. In vivo and in vitro studies showed increased senescence markers in calcified tissues and VSMCs exposed to uremic serum. NRF2 expression correlated with calcification in vivo but was depleted in vitro. These findings highlight the therapeutic potential of targeting senescence and the NRF2 pathway in the treatment of VC in CKD.
Article Medicine, Research & Experimental

A normative microbiome is not restored following kidney transplantation

Hannah Craven, Helen Erlandsson, Dagmara Mcguinness, David H. Mcguinness, Denise Mafra, Umer Zeeshan Ijaz, Peter Bergman, Paul G. Shiels, Peter Stenvinkel

Summary: This study investigated the bacterial DNA signatures in the circulation of CKD patients and those receiving KTx treatment. The results suggest that dysbiosis increases as CKD progresses, accompanied by an increase in trimethylamine (TMA) producing pathobionts Pseudomonas and Bacillus. Surprisingly, KTx patients displayed a significantly different microbiota compared to CKD5 patients, with further increase in TMA producing Bacillus and loss of salutogenic Lactobacilli. Two genera (Veillonella and Saccharimonidales) showed significant differences in abundance following KTx, reflecting a reciprocal relationship between TMA producers and utilisers.

CLINICAL SCIENCE (2023)

Review Food Science & Technology

Gut Microbiota Interventions to Retain Residual Kidney Function

Denise Mafra, Julie A. Kemp, Natalia A. Borges, Michelle Wong, Peter Stenvinkel

Summary: Residual kidney function is associated with better quality of life and outcome for patients with chronic kidney disease (CKD), and strategies should be implemented to preserve kidney function. Gut dysbiosis due to increased uremic toxin production and endotoxemia is a major cause of kidney damage, and various strategies, including diet, medications, and faecal transplantation, have been proposed to modulate the gut microbiota in these patients. Modifying gut microbiota composition may mitigate chronic kidney damage and preserve residual kidney function, but the effects of diet on residual kidney function remain limited.

TOXINS (2023)

Article Biochemistry & Molecular Biology

Urine Peptidome Analysis Identifies Common and Stage-Specific Markers in Early Versus Advanced CKD

Sam Hobson, Emmanouil Mavrogeorgis, Tianlin He, Justyna Siwy, Thomas Ebert, Karolina Kublickiene, Peter Stenvinkel, Harald Mischak

Summary: Analyzing the urinary peptidome in CKD patients has identified specific disease progression molecules in early and late stages of the disease. Structural changes may be reversible in the early stage. The results of this study have important implications for guiding patient management.

PROTEOMES (2023)

Correction Urology & Nephrology

Why not turn Food Deserts at medical conferences into educational tools for a sustainable future? (Mar, 10.1007/s40620-023-01624-w, 2023)

Carla Maria Avesani, Peter Stenvinkel, Alice Sabatino, Claudia D'Alessandro, Giorgina Barbara Piccoli

JOURNAL OF NEPHROLOGY (2023)

Review Urology & Nephrology

Cinnamon: an aromatic condiment applicable to chronic kidney disease

Laiis de Souza Gouveia Moreira, Isabela de Souza da Costa Brum, Drielly C. M. de Vargas Reis, Liana Trugilho, Tuany R. Chermut, Marta Esgalhado, Ludmila F. M. F. Cardozo, Peter Stenvinkel, Paul G. Shiels, Denise Mafra

Summary: Cinnamon, a widely used spice and traditional herbal medicine, may have beneficial effects on cardiovascular disease, obesity, and diabetes. However, its effectiveness for chronic kidney disease (CKD) remains uncertain. Bioactive compounds in cinnamon can mitigate common complications in CKD patients, such as oxidative stress, inflammation, hyperglycemia, gut dysbiosis, and dyslipidemia. This narrative review explores the mechanisms by which cinnamon may alleviate CKD complications and its potential role as an additional nutritional strategy for this patient group.

KIDNEY RESEARCH AND CLINICAL PRACTICE (2023)

Review Urology & Nephrology

Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: a narrative review

Fabiola Martin-del-Campo, Carla Maria Avesani, Peter Stenvinkel, Bengt Lindholm, Alfonso M. Cueto-Manzano, Laura Cortes-Sanabria

Summary: Protein-energy wasting (PEW) is common in patients with chronic kidney disease (CKD) and is associated with increased morbidity and mortality, and lower quality of life. Gut dysbiosis plays an important role in inflammation and uremic toxin retention, contributing to the development of PEW. Understanding the interactions between gut microbiota and the host may lead to the development of new strategies to improve nutrition and clinical outcomes in CKD patients.

JOURNAL OF NEPHROLOGY (2023)

Review Urology & Nephrology

Muscle fat infiltration in chronic kidney disease: a marker related to muscle quality, muscle strength and sarcopenia

Carla Maria Avesani, Aline Miroski de Abreu, Heitor S. Ribeiro, Torkel B. Brismar, Peter Stenvinkel, Alice Sabatino, Bengt Lindholm

Summary: Muscle fat infiltration (MFI), also known as myosteatosis, refers to the accumulation of lipids in the skeletal muscle. MFI is usually assessed using imaging methods like CT, MRI, and ultrasound, primarily in the legs, arms, and trunk muscle groups. MFI is considered a marker of muscle quality, where higher fat deposition in the muscle leads to decreased contraction power and force production per unit of muscle mass.

JOURNAL OF NEPHROLOGY (2023)

暂无数据